Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

Drug Discovery Re-Invented; Emerging Role of Biotechs, Academics and Non-Profits

16 Oct 2013 - 19 Oct 2013 - Scottsdale, AZ, USA

Bookmark and Share

Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13

The conference will center on new approaches to drug discovery in an industry where the landscape is changing rapidly. With large pharma reducing investment in internal early stage research, drug pipelines will increasingly be filled by alternative sources. These players include: government, academic labs, non-profits, biotech companies, and pharmaceutical “open innovation” models. The conference will also provide examples of successful strategies for advancing new drug candidates in this era of distributed discovery.

The full programme is now available, please see conference website for details!

Key Sessions include:

  1. Discovery Re-Invented
  2. Novel Pharma Approaches
  3. Collaborative Drug Discovery
  4. Natural Products
  5. Structure, Modelling and Informatics
  6. Biologics and Non-traditional Therapeutics
  7. Discovery Technologies

This conference is designed to attract the following attendees: medicinal, computational, and synthetic organic chemists; structural and screening biologists; research management and entrepreneurs; industrial and academic scientists.

Confirmed Speakers:

Prof. William Jorgensen (Plenary), Yale University
Prof. Jef De Brabander, UT Southwestern Medical
Dr. Bart DeCorte, Janssen Research & Development
Prof. James Barrow, Johns Hopkins School of Medicine
Dr. Ken Duncan (Plenary), Bill & Melinda Gates Foundation
Dr. Guy Breitenbucher, Dart Neuroscience
Dr. Barry Bunin, Collaborative Drug Discovery
Dr. Paul Labute, Chemical Computing Group
Dr. Leah Frye, Schrodinger
Prof. Sean Brady, The Rockefeller University
Dr. Steven Young (Plenary), BeiGene
Dr. Craig Thomas, NIH Chemical Genomics Center
Dr. Michael Trzoss, Trius Therapeutics
Dr. Joseph Vacca, WuXi AppTec
Dr. Michael Goetz, Natural Products Discovery Institute
Prof. George Georgiou, The University of Texas at Austin
Dr. Benjamin Blass, Temple University School of Pharmacy
Prof. Kenneth Merz, University of Florida
Dr. Michael Foley (Plenary), Broad Institute
Dr. David Gorenstein, University of Texas HSC Houston
Dr. Zhengying Pan, Peking University, Shenzhen Graduate School
Dr. Andreas G. Bader, Mirna Therapeutics
Dr. Todd Chappell, NIH and BioHealth Innovation
Dr. Trevor Hallam, Sutro Biopharma
Dr. Patrick Lam, Lam Drug Discovery Consulting
Dr. Sandhya Kortagere, Drexel University College of Medicine
Dr. Mark McDonnell, Fox Chase Chemical Diversity Center
Dr. Serge L Boulet, Eli Lilly
Dr. Gabor Butora, Merck
Dr. Janet L. Ralbovsky, University of Tennessee Research Foundation
Dr. Paul Leeson, GlaxoSmithKline
Dr. Matthew Segall, Optibrium Ltd.
Dr. Guy Carter, Biosortia Pharmaceuticals
Dr. Chris Williams, Chemical Computing Group

Poster Submission Deadline: 14-Aug-13
Registration Deadline: 21-Aug-13

Further information
Scientific News
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Removing 62 Barriers to Pig–to–Human Organ Transplant in One Fell Swoop
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Biomarker Predicting Transplant Complications May be Key to Treating Them
A protein that can be used to predict if a stem cell transplant patient will suffer severe complications may also be the key to preventing those complications, an international research team based at the Indiana University School of Medicine reported Wednesday.
Potential New Diagnosis and Therapy for Breast Cancer
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now’s Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.
First Results Describing Sick Sea Star Immune Response
Though millions of sea stars along the West Coast have perished in the past several years from an apparent wasting disease, scientists still don’t know why.
New Protein Cleanup Factors Found to Control Bacterial Growth
UMass Amherst researchers characterize previously mysterious proteolysis factors.
UC San Diego Team Up with Illumina to Speed-Read Your Microbiome
Data analysis app accelerates studies aimed at using microbes to predict, diagnose and treat human diseases.
Proteins with ALS, Cancer Role Do Not Assume a Regular Shape
Our cells contain proteins, essential to functions like protein creation and DNA repair but also involved in forms of ALS and cancer, that never take a characteristic shape, a new study shows.
Paving the Way for Diamonds to Trace Early Cancers
Researchers from the University of Sydney reveal how nanoscale 'diamonds' can light up early-stage cancers in MRI scans.
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos